These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2931319

  • 1. [Lack of correlation between HLA haplotypes and familial hypertrophic cardiomyopathy].
    Tabacchi G, Fantasia R, Gaboardi D, Callegari M, Deserò D.
    G Ital Cardiol; 1985 Apr; 15(4):384-6. PubMed ID: 2931319
    [Abstract] [Full Text] [Related]

  • 2. [Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
    Moiseev VS, Polianskaia IS, Iazdovskiĭ VV, Korovina EP, Guniia MG.
    Ter Arkh; 1987 Apr; 59(8):82-5. PubMed ID: 3500526
    [Abstract] [Full Text] [Related]

  • 3. Familial cardiomyopathy with variable hypertrophic and restrictive features and common HLA haplotype.
    Feld S, Caspi A.
    Isr J Med Sci; 1992 May; 28(5):277-80. PubMed ID: 1597356
    [Abstract] [Full Text] [Related]

  • 4. A clinical, genetic and echocardiographic study of hypertrophic cardiomyopathy in a large family.
    D'Onofrio F, Passariello N, Sepe J, Gentile S, Cacciapuoti F, Stabile M, Pace E, Del Covillo G, Vacca C, Ventruto V.
    Eur J Med; 1993 Apr; 2(4):227-31. PubMed ID: 8261076
    [Abstract] [Full Text] [Related]

  • 5. [Familial study and HLA analysis in hypertrophic cardiomyopathy].
    Huo YX.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Aug; 16(4):225-7. PubMed ID: 3229334
    [No Abstract] [Full Text] [Related]

  • 6. [HLA-DRW grouping in obstructive myocardiopathy].
    Becqué O, Bernard Y, Bassand JP, Hervé P, Maurat JP.
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1359-62. PubMed ID: 6439160
    [Abstract] [Full Text] [Related]

  • 7. [Hypertrophic cardiomyopathy occurring in the family. Rare coexistence with oligophrenia. Clinical examinations, cytogenetic and HLA system].
    Krzymińska E, Szczerkowska Z, Linom J, Swiatecka G, Pawlak T, Maniszewska B, Luberda Z.
    Kardiol Pol; 1993 Aug; 39(8):84-9; discussion 90. PubMed ID: 8231010
    [Abstract] [Full Text] [Related]

  • 8. HL-A and hypertrophic cardiomyopathy.
    Matsumori A, Hirose K, Wakabayashi A, Kawai C, Nabeya N, Sakurami T, Tsuji K.
    Am Heart J; 1979 Apr; 97(4):428-31. PubMed ID: 154832
    [Abstract] [Full Text] [Related]

  • 9. Familial and sporadic hypertrophic myopathy: differences and similarities in a genotyped population. A long follow-up study.
    Brito D, Richard P, Komajda M, Madeira H.
    Rev Port Cardiol; 2008 Feb; 27(2):147-73. PubMed ID: 18488914
    [Abstract] [Full Text] [Related]

  • 10. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 11. [Occurrence of HLA-antigens in patients with hypertrophic cardiomyopathy].
    Bodem R, Zipperle S, Ho A, Lenhard V.
    Z Kardiol; 1982 Dec; 71(12):820-3. PubMed ID: 6962579
    [Abstract] [Full Text] [Related]

  • 12. [Immunogenetic study in hypertrophic cardiomyopathy].
    Gregor P, Ivasková E, Sajdlová H, Kupková L, Widimský P, Cervenka V.
    Vnitr Lek; 1992 May; 38(5):466-72. PubMed ID: 1509716
    [Abstract] [Full Text] [Related]

  • 13. HLA haplotypes in familial Graves' disease.
    Farid NR, Moens H, Larsen B, Payne R, Saltman K, Fifield F, Ingram DW.
    Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
    [Abstract] [Full Text] [Related]

  • 14. [Hypertrophic cardiomyopathy: family study and HLA analysis (author's transl)].
    Kishimoto C, Takatsu Y, Takayama S, Yokoyama S, Hanyu I, Kaburagi T, Hosono F.
    Kokyu To Junkan; 1981 Jan; 29(1):79-86. PubMed ID: 7196074
    [No Abstract] [Full Text] [Related]

  • 15. [Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features].
    Seo T, Yokota Y, Maehashi N, Takarada A, Kubo M, Toh S, Nakanishi O, Masuda J, Fujitani K, Fukuzaki H.
    J Cardiogr; 1986 Mar; 16(1):81-94. PubMed ID: 3782892
    [Abstract] [Full Text] [Related]

  • 16. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, Mathieu B, Bonne G, Gary F, Charron P, Hagege M, Komajda M, Schwartz K, Hainque B.
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [Abstract] [Full Text] [Related]

  • 17. [HLA haplotypes in young myocardial infarct patients (a family study)].
    Kuz'mina AA, Latfullin IA.
    Ter Arkh; 1998 Jul; 70(8):33-7. PubMed ID: 9770741
    [Abstract] [Full Text] [Related]

  • 18. Possible association of specific HLA haplotype in a pedigree with familial polyposis coli.
    Nagatomo Y, Yoshida T, Kodama K, Kambe H, Tanaka K.
    Am J Gastroenterol; 1987 Sep; 82(9):910-1. PubMed ID: 2820223
    [Abstract] [Full Text] [Related]

  • 19. Two forms of hypertrophic cardiomyopathy distinguished by inheritance of HLA haplotypes and left ventricular outflow tract obstruction.
    Kishimoto C, Kaburagi T, Takayama S, Yokoyama S, Hanyu I, Takatsu Y, Tomimoto K.
    Am Heart J; 1983 Jun; 105(6):988-94. PubMed ID: 6683070
    [Abstract] [Full Text] [Related]

  • 20. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Jun; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.